High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age

Journal of Alzheimer's Disease

Volumn 20, Issue 4, 2010, Pages 1029-1037

  Mangialasche, Francesca ^a,b   Kivipelto, Miia ^a   Mecocci, Patrizia ^b   Rizzuto, Debora ^a   Palmer, Katie ^a,c   Winblad, Bengt ^a   Fratiglioni, Laura ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF PERUGIA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Alzheimer's disease; elderly; oxidative stress; tocopherol; tocotrienol; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; BETA TOCOPHEROL; BETA TOCOTRIENOL; CHOLESTEROL; DELTA TOCOPHEROL; DELTA TOCOTRIENOL; GAMMA TOCOPHEROL; GAMMA TOCOTRIENOL; UNCLASSIFIED DRUG;

AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HUMAN; INCIDENCE; KATZ INDEX; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SENESCENCE; SMOKING HABIT; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; AGING; ANALOGS AND DERIVATIVES; BLOOD; CHEMICALLY INDUCED; DEMENTIA; INFORMATION PROCESSING; NEUROPSYCHOLOGICAL TEST; NUTRITIONAL STATUS; PHYSIOLOGY; POPULATION; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; SOCIOECONOMICS; SWEDEN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; CHOLESTEROL; DATA COLLECTION; DEMENTIA; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NUTRITIONAL STATUS; POPULATION; PROPORTIONAL HAZARDS MODELS; RISK REDUCTION BEHAVIOR; SOCIOECONOMIC FACTORS; SWEDEN; VITAMIN E;

EID: 77954559376     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-091450     Document Type: Article

References (44)

1. Sayre LM, Perry G, Smith MA (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21, 172-188.
2. Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R, Mecocci P (2009) Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev 8, 285-305.
3. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 24, 915-919.
4. Pratic̀o D, Sung S (2004) Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 6, 171-175.
5. Kamat CD, Gadal S, Mhatre M, Williamson KS, Pye QN, Hensley K (2008) Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis 15, 473-493.
6. BurtonGW, TraberMG(1990)Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr 10, 357-382.
7. Muller DP, Goss-Sampson MA (1990) Neurochemical, neurophysiological, and neuropathological studies in vitamin E deficiency. Crit Rev Neurobiol 5, 239-263.
8. Engelhart MJ, Ruitenberg A, Meijer J, Kiliaan A, van Swieten JC, Hofman A, Witteman JC, Breteler MM (2005) Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline. Dement Geriatr Cogn Disord 19, 134-139.
9. Helmer C, Peuchant E, Letenneur L, Bourdel-Marchasson I, Larrieu S, Dartigues JF, Dubourg L, Thomas MJ, Barberger- Gateau P (2003) Association between antioxidant nutritional indicators and the incidence of dementia: results from the PAQUID prospective cohort study. Eur J Clin Nutr 57, 1555-1561.
10. Ravaglia G, Forti P, Lucicesare A, Pisacane N, Rietti E, Mangialasche F, Cecchetti R, Patterson C, Mecocci P (2008) Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort. Am J Clin Nutr 87, 1306-1313.
11. Sundelof J, Kilander L, Helmersson J, Larsson A, Ronnemaa E, Degerman-Gunnarsson M, Sjogren P, Basun H, Lannfelt L, Basu S (2009) Systemic tocopherols and F2-isoprostanes and the risk of Alzheimer's disease and dementia: a prospective population-based study. J Alzheimers Dis 18, 71-78.
12. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS, Aggarwal NT, Scherr PA (2005) Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr 81, 508-514.
13. Luchsinger JA, Tang MX, Shea S, Mayeux R (2003) Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 60, 203-208.
14. Laurin D, Foley DJ, Masaki KH, White LR, Launer LJ (2002) Vitamin E and C supplements and risk of dementia. JAMA 288, 2266-2268.
15. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287, 3223-3229.
16. Isaac MG, Quinn R, Tabet N(2008) Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev, CD002854.
17. Brigelius-Floh́e R, TraberMG(1999) Vitamin E: function and metabolism. FASEB J 13, 1145-1155.
18. Zingg JM (2007) Molecular and cellular activities of vitamin E analogues. Mini Rev Med Chem 7, 543-558.
19. Suzuki YJ, Tsuchiya M,Wassall SR, Choo YM, Govil G, Kagan VE, Packer L (1993) Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry 32, 10692-10699.
20. Williamson KS, Gabbita SP, Mou S,West M, Pye QN, Markesbery WR, Cooney RV, Grammas P, Reimann-Philipp U, Floyd RA, Hensley K (2002) The nitration product 5-nitro-gammatocopherol is increased in the Alzheimer brain. Nitric Oxide 6, 221-227.
21. Nesaretnam K (2008) Multitargeted therapy of cancer by tocotrienols. Cancer Lett 269, 388-395.
22. Reiter E, Jiang Q, Christen S (2007) Anti-inflammatory properties of alpha- and gamma-tocopherol. Mol Aspects Med 28, 668-691.
23. Sen CK, Khanna S, Rink C, Roy S (2007) Tocotrienols: the emerging face of natural vitamin E. Vitam Horm 76, 203-261.
24. Fratiglioni L, Viitanen M, Backman L, Sandman PO,Winblad B (1992) Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology 11 Suppl 1, 29-36.
25. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B (1997) Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 48, 132-138.
26. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
27. Marengoni A,Winblad B, Karp A, Fratiglioni L (2008) Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. Am J Public Health 98, 1198-1200.
28. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185, 914-919.
29. Nordic Council on Medicines (1985) Guidelines for ATCClassification., Nordic Council on Medicines, Uppsala, Sweden.
30. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed.-Revised (DSM III R), (1987) American Psychiatric Association Washington DC.
31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
32. Traber MG, Jialal I (2000) Measurement of lipid-soluble vitamins-further adjustment needed? Lancet 355, 2013-2014.
33. Wright ME, Lawson KA,Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, Albanes D (2006) Higher baseline serum concentrations of vitamin E are associated with lower total and causespecific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 84, 1200-1207.
34. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795.
35. Galli F, Polidori MC, Stahl W, Mecocci P, Kelly FJ (2007) Vitamin E biotransformation in humans. Vitam Horm 76, 263-280.
36. Fairus S, Nor RM, Cheng HM, Sundram K (2006) Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of alpha-tocopherol. Am J Clin Nutr 84, 835-842.
37. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12, 1005-1015.
38. Naito Y, Shimozawa M, Kuroda M, Nakabe N, Manabe H, Katada K, Kokura S, Ichikawa H, Yoshida N, Noguchi N, Yoshikawa T (2005) Tocotrienols reduce 25- hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 180, 19-25.
39. Kang JH, Grodstein F (2008) Plasma carotenoids and tocopherols and cognitive function: a prospective study. Neurobiol Aging 29, 1394-1403.
40. Dixon LB, Subar AF, Wideroff L, Thompson FE, Kahle LL, Potischman N (2006) Carotenoid and tocopherol estimates from the NCI diet history questionnaire are valid compared with multiple recalls and serum biomarkers. J Nutr 136, 3054-3061.
41. Gutierrez AD, de Serna DG, Robinson I, Schade DS (2009) The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C. Metabolism 58, 469-478.
42. Khanna S, Patel V, Rink C, Roy S, Sen CK (2005) Delivery of orally supplemented alpha-tocotrienol to vital organs of rats and tocopherol-transport protein deficient mice. Free Radic Biol Med 39, 1310-1319.
43. Ford ES, Ajani UA, Mokdad AH (2005) Brief communication: The prevalence of high intake of vitamin E from the use of supplements among U.S. adults. Ann Intern Med 143, 116-120.
44. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297, 842-857.